The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL ...

More women who are having children have been diagnosed with an autoimmune condition since the millennium, sparking new ...

Ginger tea is loaded with antioxidants and compounds that help lower inflammation. Chronic inflammation plays a role in ...

The deal gives Cullinan T cell engagers aimed at BCMA and CD19, which drugmakers are exploring as possible targets for ...

Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...

In return for the ex-China rights to its new addition, called velinotamig, Cullinan has agreed to pay Genrix Bio the upfront ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing ...

More than 200 inmates escaped from a jail in the southern Pakistani city of Karachi late on Monday when they overpowered ...